GM20613
Fibroblast from Umbilical Cord, Vein, umbilical
Description:
NEPHROSIS 1, CONGENITAL, FINNISH TYPE; NPHS1
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases |
|
Biopsy Source
|
Vein, umbilical
|
|
Cell Type
|
Fibroblast
|
|
Tissue Type
|
Umbilical Cord
|
|
Transformant
|
Untransformed
|
|
Sample Source
|
Fibroblast from Umbilical Cord, Vein, umbilical
|
|
Family Member
|
1
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| PDL at Freeze |
3 |
| Passage Frozen |
2 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin confirmed by LINE assay |
| |
| Remarks |
Clinically affected; maternal serum alpha-fetoprotein during mother's pregnancy was 5.10 MOM; amniotic fluid alpha-fetoprotein was 43.34 MOM (494.10 ug/ml); chromosome analysis on amniocentesis sample revealed two cell lines, 46,XY in 15 colonies from 3 independent cultures and 46,XX in 5 colonies from 3 independent cultures; autopsy on fetus of the mother's previous pregnancy diagnosed congenital Finnish nephrosis: electron microscopy documented visceral epithelial cell foot process effacement and microvillous formation and presence of scattered foci of tubular dilatation; NPHS1 mutation analysis on previous fetus was negative; mother is GM20614; father is GM20615 |
| Cumulative PDL at Freeze |
2.76 |
| Passage Frozen |
2 |
| Split Ratio |
1:6 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
10% fetal bovine serum Not inactivated |
| Substrate |
None specified |
| Subcultivation Method |
trypsin-EDTA |
| Supplement |
- |
|
|